Literature DB >> 2365822

A human Ro/SS-A autoantigen is the homologue of calreticulin and is highly homologous with onchocercal RAL-1 antigen and an aplysia "memory molecule".

D P McCauliffe1, E Zappi, T S Lieu, M Michalak, R D Sontheimer, J D Capra.   

Abstract

The Ro/SS-A (Ro) autoantigens consist of at least four immunologically distinct proteins which are recognized by autoantibodies typically found in sera from patients with primary Sjogren's syndrome and in subsets of patients with lupus erythematosus. We recently isolated a 1.9-kb human cDNA clone which encodes one of these Ro autoantigens. Synthetic oligonucleotides corresponding to the human Ro sequence were used to amplify the homologous gene from a murine B cell cDNA library using the polymerase chain reaction. The mouse cDNA-encoded amino acid sequence was found to be 94% homologous to the human Ro sequence and is 100% homologous to murine calreticulin, a high affinity calcium-binding protein which resides in the endoplasmic and sarcoplasmic reticulum. The amino acid sequence of rabbit calreticulin is 92% homologous to both murine calreticulin and human Ro. Onchocerca volvulus and Drosophila melanogaster also have molecules that are highly homologous to human Ro. In addition, human Ro has a molecular mass, isoelectric point, and significant amino acid sequence similar to the Aplysia californica snail neuronal protein 407. These homologies suggest that this Ro protein has a very basic cellular function(s) which may in part involve calcium binding.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2365822      PMCID: PMC296725          DOI: 10.1172/JCI114704

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  24 in total

1.  Molecular cloning, expression, and chromosome 19 localization of a human Ro/SS-A autoantigen.

Authors:  D P McCauliffe; F A Lux; T S Lieu; I Sanz; J Hanke; M M Newkirk; L L Bachinski; Y Itoh; M J Siciliano; M Reichlin
Journal:  J Clin Invest       Date:  1990-05       Impact factor: 14.808

2.  Characterization of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythmatosus.

Authors:  G Clark; M Reichlin; T B Tomasi
Journal:  J Immunol       Date:  1969-01       Impact factor: 5.422

3.  Direct hybridization of labeled DNA to DNA in agarose gels.

Authors:  M Purrello; I Balazs
Journal:  Anal Biochem       Date:  1983-02-01       Impact factor: 3.365

4.  Homozygous C2 deficiency, lupus erythematosus, and anti-Ro (SSA) antibodies.

Authors:  T T Provost; F C Arnett; M Reichlin
Journal:  Arthritis Rheum       Date:  1983-10

5.  Identification of the SS-A/Ro intracellular antigen with autoimmune sera.

Authors:  T S Lieu; M Jiang; J C Steigerwald; E M Tan
Journal:  J Immunol Methods       Date:  1984-07-06       Impact factor: 2.303

6.  The importance of tissue substrate in the SS-A/Ro antigen-antibody system.

Authors:  C E Harmon; J S Deng; C L Peebles; E M Tan
Journal:  Arthritis Rheum       Date:  1984-02

7.  Serological findings in patients with "ANA-negative" systemic lupus erythematosus.

Authors:  P J Maddison; T T Provost; M Reichlin
Journal:  Medicine (Baltimore)       Date:  1981-03       Impact factor: 1.889

8.  Neonatal lupus erythematosus: new serologic findings.

Authors:  D C Kephart; A F Hood; T T Provost
Journal:  J Invest Dermatol       Date:  1981-09       Impact factor: 8.551

9.  Serologic and HLA associations in subacute cutaneous lupus erythematosus, a clinical subset of lupus erythematosus.

Authors:  R D Sontheimer; P J Maddison; M Reichlin; R E Jordon; P Stastny; J N Gilliam
Journal:  Ann Intern Med       Date:  1982-11       Impact factor: 25.391

10.  Ro small cytoplasmic ribonucleoproteins are a subclass of La ribonucleoproteins: further characterization of the Ro and La small ribonucleoproteins from uninfected mammalian cells.

Authors:  J P Hendrick; S L Wolin; J Rinke; M R Lerner; J A Steitz
Journal:  Mol Cell Biol       Date:  1981-12       Impact factor: 4.272

View more
  30 in total

Review 1.  C1q receptors.

Authors:  P Eggleton; A J Tenner; K B Reid
Journal:  Clin Exp Immunol       Date:  2000-06       Impact factor: 4.330

Review 2.  B-cell epitopes of La and Ro autoantigens.

Authors:  S Whittingham
Journal:  Mol Biol Rep       Date:  1992-06       Impact factor: 2.316

Review 3.  Calreticulin.

Authors:  M Michalak; R E Milner; K Burns; M Opas
Journal:  Biochem J       Date:  1992-08-01       Impact factor: 3.857

Review 4.  Systemic lupus erythematosus: RNA-protein autoantigens, models of disease heterogeneity, and theories of etiology.

Authors:  J B Harley; R H Scofield
Journal:  J Clin Immunol       Date:  1991-11       Impact factor: 8.317

5.  Identification of abundantly expressed novel and conserved genes from the infective larval stage of Toxocara canis by an expressed sequence tag strategy.

Authors:  K K Tetteh; A Loukas; C Tripp; R M Maizels
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

6.  5' sequences of rubella virus RNA stimulate translation of chimeric RNAs and specifically interact with two host-encoded proteins.

Authors:  G P Pogue; X Q Cao; N K Singh; H L Nakhasi
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

7.  The rubella virus RNA binding activity of human calreticulin is localized to the N-terminal domain.

Authors:  C D Atreya; N K Singh; H L Nakhasi
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

8.  Calreticulin synthetic peptide analogues: anti-peptide antibodies in autoimmune rheumatic diseases.

Authors:  J G Routsias; A G Tzioufas; M Sakarellos-Daitsiotis; C Sakarellos; H M Moutsopoulos
Journal:  Clin Exp Immunol       Date:  1993-03       Impact factor: 4.330

Review 9.  Diversity and origin of rheumatologic autoantibodies.

Authors:  M J Fritzler; M Salazar
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

10.  Purification of an inositol 1,4,5-trisphosphate-binding calreticulin-containing intracellular compartment of HL-60 cells.

Authors:  C Van Delden; C Favre; A Spät; E Cerny; K H Krause; D P Lew
Journal:  Biochem J       Date:  1992-02-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.